Posted on October 11, 202110/11/21
EVERSANA™ named a Great Place to Work for third consecutive year in U.S.; earns valuable recognition in Canada, China and India
Posted on October 5, 202110/5/21
EVERSANA joins phactMI Corporate Partner Program, helping to shape the future of medical information services
Posted on September 2, 20219/2/21
Novartis Strikes “World First” Deal With UK NHS Following Leqvio NICE Recommendation
Posted on August 17, 20218/17/21
Shorla Pharma Announces Partnership with EVERSANA to Support the Launch and Commercialization of T-cell Leukemia Treatment
Posted on August 5, 20218/5/21
Our commitment to a healthier world: EVERSANA’s vaccine requirements for employees
Posted on July 30, 20217/30/21
U.S. Lawmakers Request Transparency on Defense Department’s Use of March-in Power to Reduce Drug Prices
Posted on July 29, 20217/29/21
Israel Embarks on Partnership with FDA’s Project Orbis, Generic Drug Cluster
Posted on July 28, 20217/28/21
Zorginstituut Advises 5% Price Reduction for Yescarta Following Reassessment of Survival Data
Posted on July 23, 20217/23/21